AVCJ

Japan health tech player SmartScan gets $10m Series A

  • LinkedIn  
  • Google plus  
  • Save this article  

SmartScan, a Japanese medical technology supplier focused on software for diagnostics equipment, has raised a JPY1.3 billion ($10.3 million) Series A round from domestic VCs.

Participants included DG Incubation, Nippon Venture Capital, and Scrum Ventures, as well as pharmaceuticals company Miraca Holdings. Surgical instruments specialist Cyberdyne also contributed via its Cybernics Excellence Japan Fund, which was set up last year at JPY9.2 billion.

SmartScan provides image recognition technology that uses artificial intelligence (AI) to collect and analyze patient information with a view to detect pre-symptomatic disease. Data is accumulated by a brain scanning service that is said to be easier to use than convention equipment for brain, heart and lung examinations. The fresh capital will be used to expand the company's network of partnering clinics.

According to a release, SmartScan will also enter into a partnership with Cyberdyne to develop a cybernetics industry "that will fuse and combine human with cyber/physical space."

Cyberdyne plans to combine SmartScan's expertise in collecting brain data with its own capabilities related to information on vital systems and patient behavior with a view to developing big data systems in fields such as medicine, nursing care, and workplace health.  

  • LinkedIn  
  • Google plus  
  • Save this article  

More on North Asia

Latest News

Asian GPs slow implementation of ESG policies - survey
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs